CBD Life Sciences (CBD Life Sciences) Change In Payables And Accrued Expense : $-0.04 Mil (TTM As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Change In Payables And Accrued Expense?

CBD Life Sciences's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2015 was $0.00 Mil. It means CBD Life Sciences's Accounts Payable & Accrued Expense stayed the same from Jun. 2015 to Sep. 2015 .

CBD Life Sciences's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2014 was $-0.04 Mil. It means CBD Life Sciences's Accounts Payable & Accrued Expense declined by $0.04 Mil from Dec. 2013 to Dec. 2014 .

CBD Life Sciences Change In Payables And Accrued Expense Historical Data

The historical data trend for CBD Life Sciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Change In Payables And Accrued Expense Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Change In Payables And Accrued Expense

0.11

-0.04

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Change In Payables And Accrued Expense	Get a 7-Day Free Trial											0.10	-0.14	-	-	-

CBD Life Sciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

CBD Life Sciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.